There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the University of Washington and director of HIV treatment initiatives at the King County, Seattle public health department.
Addressing HIV in the homeless population is difficult but not impossible and there are three methods to do so, according to a recent review called ‘The impact of homelessness and housing insecurity on HIV,’ published in Lancet HIV.
The first is low-barrier care, which focuses on providing medical care for patients unable to engage in more traditional healthcare, such as making an appointment to see a provider. Low-barrier care clinics offer things like walk-in appointments and social work. Incentives such as clothing or food may encourage people to visit these centers.
The second method is mobile care, in which providers meet the patient in the field.
The last option is long-acting injectable medications, such as lenacapavir. However, these drugs are largely inaccessible due to price. When used as a form of preexposure prophylaxis, lenacapavir currently costs approximately $44,819 per person per year.
“I think low-barrier care is the most promising because it's a flexible model and can be done in different ways, in different systems,” Julie Dombrowski, M.D., M.P.H., professor of medicine at the University of Washington, director of HIV treatment initiatives at the public health department of Seattle, King County and lead author, said in an interview with Managed Healthcare Executive. “Even within a conventional HIV clinic, people can make time on certain half days of the week, or with dedicated providers or with nurse-based models, to have walk-in availability for patients.”
Julie Dombrowski, M.D., M.P.H.
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More